4.5 Article

Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative Resection

Journal

JOURNAL OF HEPATOCELLULAR CARCINOMA
Volume 10, Issue -, Pages 193-202

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/JHC.S393286Journalof

Keywords

hepatocellular carcinoma; AFP-negative; inflammation; NrLR; liver resection; prognosis

Categories

Ask authors/readers for more resources

This study investigates the clinical significance of inflammation-related markers in AFP-negative HCC patients after curative resection. The results show that neutrophil times gamma-glutamyl transpeptidase to lymphocyte ratio (NrLR) is an independent risk factor associated with patient survival and tumor recurrence. Low NrLR groups have better outcomes and tumor characteristics compared to high NrLR groups. NrLR can be a simple and low-cost marker to assess prognosis and guide clinical surveillance in AFP-negative HCC patients.
Background: The role of inflammation-related markers in alpha-fetoprotein (AFP) negative hepatocellular carcinoma (HCC) is not well known. This study aimed to investigate the clinical significance of inflammation-related markers in AFP-negative HCC patients after curative resection. Methods: One thousand one hundred and seventy-nine AFP-negative HCC patients after curative resection were included. Survival rate and prognostic analysis were performed using Kaplan-Meier and Cox regression analysis. Propensity score matching (PSM) was used for patient selection. Results: Multivariate Cox regression showed that neutrophil times gamma-glutamyl transpeptidase to lymphocyte ratio (NrLR) was the independent risk factor associated with OS (p = 0.002) and RFS (p = 0.017). Low NrLR groups (n = 628) had lower rates of albuminbilirubin (ALBI) grade 2 (p < 0.001), lower rates of bleeding and blood transfusion (p < 0.001) than high NrLR groups. Considering tumor features, low NrLR groups had lower AFP levels (p < 0.001), smaller tumor size (p < 0.001), and lower rates of Edmondson grade III-IV (p = 0.024) than high NrLR groups. After PSM, the 1-year, 3 year-, and 5-year OS rates in the low NrLR and high NrLR groups were 96.3%, 86.9%, 64.9%, and 91.4%, 76.7%, 59.5% (p < 0.001), respectively. The 1-year, 3-year, and 5-year RFS rates in the low NrLR and high NrLR groups were 80.0%, 62.9%, 47.5%, and 71.7%, 52.6%, 39.5% (p < 0.001), respectively. Conclusion: NrLR was a poor prognostic factor for mortality and tumor recurrence in AFP-negative HCC patients after curative resection. The simple and low-cost marker could help physician to determine patients at high risk of tumor recurrence for frequent clinical surveillance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available